Martini, Alberto http://orcid.org/0000-0003-1272-7154
Shah, Qainat N.
Waingankar, Nikhil
Sfakianos, John P.
Tsao, Che-Kai
Necchi, Andrea
Montorsi, Francesco
Gallagher, Emily J. http://orcid.org/0000-0002-7920-8474
Galsky, Matthew D.
Article History
Received: 14 March 2021
Revised: 25 May 2021
Accepted: 22 June 2021
First Online: 5 July 2021
Declarations (Ethics):
:
: MDG has served as consultant for BioMotiv, Janssen, Merk, Dendreon, GlaxoSmithKline, Lilly, Astellas, Genetech, BMS, Novartis, Pfizer, EMD Serono, AZ, Seattle Genetics, Incyte, Aileron Therapeutics, Dracen, Inovio Pharmaceuticals, NuMab, has received research funding from Janssen, Merk, Dendreon, Novartis, BMS, AZ, Genentech/Roche, and owns stock of Rapt Therapeutics, outside the submitted work. AN has served as a consultant for Merck, Astra Zeneca, Janssen, Incyte, Roche, Rainier Therapeutics, Clovis Oncology, Bayer, and Astellas/Seattle Genetics, Ferring, Immunomedics. has received research funding from Merck, Ipsen, and Astra Zeneca. has received Travel expenses/Honoraria from Roche, Merck, Astra Zeneca, and Janssen.